The above studies reveal that relieving inflammation can improve osteoporosis and bone metabolism disorders, which can be implemented by TNF-α inhibitor, IL-6 inhibitor, or TLR-4 inhibitor treatment. Here, TLR4 is linked to osteoporosis.